620987-63-5

Upstream product

• 91328-60-8 (allyl)2Cu(CN)Li₂ 
• 865622-63-5 2-Allyl-6-methoxy-benzoic acid (3R,5R)-2-methoxy-5-((S)-1-trifluoromethanesulfonyloxy-ethyl)-tetrahydro-furan-3-yl ester 
• 73-34-7 L-rhamnose 
• 620987-55-5 (3R,5R)-5-((1S)-1-hydroxyethyl)-2-methoxyoxolan-3-yl 6-methoxy-2-prop-2-enylbenzoate 
• 620987-54-4 (3R,5R)-5-((1S)-1-hydroxyethyl)-2-oxo-3,4,5-trihydrofuryl 6-methoxy-2-prop-2-enylbenzoate 
• 325172-28-9 2-allyl-6-methoxy-benzoic acid 
• 20031-16-7 L-Rhamnono-1,4-lactone 
• 81644-86-2 2,3,5-tri-O-benzoyl-L-rhamnono-1,4-lactone 
• 75721-93-6 2,5-di-O-benzoyl-3,6-dideoxy-L-arabino-hexono-1,4-lactone 
• 73679-22-8 (3R,5R,6S)-6-methyl-3-hydroxy-5-(hydroxyethyl)-3,4,5-trihydrofuran-2-one 

Downstream Products

• 620987-65-7 (1S,3R,4S)-1-(2-cyanoethyl)-3-hydroxy-4-methylhept-6-enyl 6-hydroxy-2-prop-2-enylbenzoate 
• 620987-56-6 (3R,5R)-5-((1S)-1-methylbut-3-enyl)-2-hydroxyoxolan-3-yl 6-hydroxy-2-prop-2-enylbenzoate 

Relevant academic research and scientific papers

Enantiospecific Formal Total Syntheses of (-)-Salicylihalamides A and B from D-Glucose and L-Rhamnose

(Matrix Presented) Two formal chiral pool syntheses of the (-)-salicylihalamides A and B were achieved from commercially available 1,2,5,6-diacetone-D-glucose and L-rhamnose.